Multiple Sclerosis, Vol. 7, No. 5, 327-334 (2001)
DOI: 10.1177/135245850100700509
© 2001 SAGE Publications
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability
Peter Flachenecker
Karlheinz Reiners
Miriam Krauser
Annalaska Wolf
Klaus V Toyka
Background: Autonomic dysfunction is frequently
observed in patients with multiple sclerosis
(MS) but the evolution over time and the relationship to clinical
characteristics are not yet established.
Objectives: We investigated the correlation of disease activity
and progression of disability with composite scores
of cardiovascular autonomic dysfunction and serum levels
of catecholamines in a cross-sectional study
of patients with clinically active and clinically stable MS.
Results: In the cross-sectional study, the number of patients with at
least one abnormal sympathetic test was higher
in the `active' patient group (39%) than in
healthy controls (8%, P50.02) or `stable' patients (0%, P50.04),
while no difference was seen in the parasympathetic
score. Median catecholamine levels were significantly
lower in `active' MS patients than in those with stable disease
(norepinephrine, 204 ng/l (interquartile range
158-310 ng/l) vs 363 ng/l (269-507 ng/l), P50.02
and epinephrine, 23 ng/l (16-28 ng/l) vs 32 ng/l (24-107 ng/l),
P50.04). In the subgroup of patients studied
longitudinally, parasympathetic but not sympathetic
dysfunction increased slightly during the follow-up period,
with a significant correlation to the increase
in clinical disability (r=0.7, P50.002).
Conclusions: Parasympathetic dysfunction was closely related
to the progression of disability in patients
with MS. In contrast, sympathetic dysfunction
was associated to the clinical activity of MS.
This is in line with previous observations suggesting that the autonomic nervous system may be intimately linked with the disordered immune regulation in MS.